India might soon be tweaking Covid-19 regulations, prioritising those with symptoms regardless of their condition or the history of their sickness as the government struggles to combat the emergence of the novel Variants of SARS-CoV-2. Reports have stated that this will conform with the current recommendations from the World Health Organization (WHO) on national SARS-CoV-2 tests and diagnostic capabilities.
In India more than 320 million Covid-19 vaccines have been provided to date, however, many of them completely vaccinated or recovered do not appear too willing to undergo a test. The intricacy is further enhanced by mutant variations such as alpha, beta, gamma, delta and delta, including those with both images.
Discussion about this post